97.18
-0.83
(-0.85%)
At close: January 31 at 3:00:00 PM EST
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | -- | -- | 2 | 2 |
Avg. Estimate | 0 | 0 | 2.39 | 3.93 |
Low Estimate | 0 | 0 | 2.29 | 3.92 |
High Estimate | 0 | 0 | 2.5 | 3.94 |
Year Ago EPS | -- | -- | 2.1 | 2.39 |
Revenue Estimate
Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | -- | -- | 8 | 16 |
Avg. Estimate | -- | -- | 5.89B | 6.78B |
Low Estimate | -- | -- | 5.77B | 6.37B |
High Estimate | -- | -- | 6.15B | 7.62B |
Year Ago Sales | -- | -- | 5.25B | 5.89B |
Sales Growth (year/est) | -- | -- | 12.20% | 15.06% |
EPS Trend
Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 2.39 | 3.93 |
7 Days Ago | 0 | 0 | 2.34 | 3.85 |
30 Days Ago | 0 | 0 | 2.34 | 3.85 |
60 Days Ago | 0 | 0 | 2.25 | 3.63 |
90 Days Ago | 0 | 0 | 2.25 | 3.63 |
EPS Revisions
Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | 1 | 1 |
Up Last 30 Days | -- | -- | 1 | 1 |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
UCBJY | -- | -- | 13.98% | 64.13% |
S&P 500 | 9.91% | 10.33% | 14.01% | 13.75% |
Upgrades & Downgrades
Upgrade | JP Morgan: Neutral to Overweight | 9/2/2021 |
Upgrade | UBS: Neutral to Buy | 8/23/2021 |
Initiated | Deutsche Bank: Buy | 7/23/2021 |
Initiated | Societe Generale: Buy | 7/9/2021 |
Related Tickers
1AEA.SG argenx SE
635.00
+2.42%
1AE.SG argenx SE
637.80
+1.75%
WXXWY WuXi Biologics (Cayman) Inc.
4.7800
+0.63%
SBM.V Sirona Biochem Corp.
0.0500
0.00%
ADAG Adagene Inc.
1.9000
+2.70%
CNTA Centessa Pharmaceuticals plc
16.92
+0.06%
ORIC ORIC Pharmaceuticals, Inc.
10.42
-3.25%
KYMR Kymera Therapeutics, Inc.
39.59
-2.13%
LGND Ligand Pharmaceuticals Incorporated
116.55
-1.76%
GUBRA.CO Gubra A/S
662.00
+0.30%